Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial
Adding carboplatin to sequential taxane–anthracycline neoadjuvant chemotherapy shows improved event-free and overall survival benefits in premenopausal women with triple-negative breast cancer
